John R. Stuelpnagel sold 20,000 10x Genomics shares at prices ranging from $60.66 to $62.61 across three transactions, leaving him with 328,436 shares. Investors can see the sale’s execution range and the insider’s resulting ownership position from the reported transaction details.

Key Highlights

  • The transactions occurred on 3 September 2026.
  • Stuelpnagel owned 328,436 shares after the transactions.
  • All three transactions carried code S.

10x Genomics, Inc. (NASDAQ: TXG) insider John R. Stuelpnagel sold 20,000 shares. The three transactions took place at prices ranging from $60.66 to $62.61 per share.

Three Transactions on 3 September 2026

The transactions were completed on 3 September 2026, with each carrying transaction code S. The activity was divided across three transactions, and the prices covered the range from $60.66 to $62.61 per share. Stuelpnagel held 328,436 shares after the transactions. 10x Genomics identifies Stuelpnagel as an insider. The reported sale involved 20,000 shares in total, while the post-transaction ownership figure was 328,436 shares.